DE60026666D1 - Induktion von antigen-spezifischen T-Zellen durch Interferon - Google Patents

Induktion von antigen-spezifischen T-Zellen durch Interferon

Info

Publication number
DE60026666D1
DE60026666D1 DE60026666T DE60026666T DE60026666D1 DE 60026666 D1 DE60026666 D1 DE 60026666D1 DE 60026666 T DE60026666 T DE 60026666T DE 60026666 T DE60026666 T DE 60026666T DE 60026666 D1 DE60026666 D1 DE 60026666D1
Authority
DE
Germany
Prior art keywords
antigen
induction
cells
specific
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60026666T
Other languages
English (en)
Other versions
DE60026666T2 (de
Inventor
Hideo Takasu
Masashi Gotoh
Takashi Yamaoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Dainippon Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Dainippon Pharma Co Ltd filed Critical Sumitomo Dainippon Pharma Co Ltd
Application granted granted Critical
Publication of DE60026666D1 publication Critical patent/DE60026666D1/de
Publication of DE60026666T2 publication Critical patent/DE60026666T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60026666T 1999-07-22 2000-07-24 Induktion von antigen-spezifischen T-Zellen durch Interferon Expired - Fee Related DE60026666T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20768799 1999-07-22
JP20768799 1999-07-22

Publications (2)

Publication Number Publication Date
DE60026666D1 true DE60026666D1 (de) 2006-05-11
DE60026666T2 DE60026666T2 (de) 2006-11-09

Family

ID=16543925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60026666T Expired - Fee Related DE60026666T2 (de) 1999-07-22 2000-07-24 Induktion von antigen-spezifischen T-Zellen durch Interferon

Country Status (4)

Country Link
EP (2) EP1681064A1 (de)
AT (1) ATE320266T1 (de)
CA (1) CA2313392A1 (de)
DE (1) DE60026666T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100767554B1 (ko) 1998-07-31 2007-10-17 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 암 억제 유전자 더블유티1의 생산물에 기초한 암항원
EP1371664B1 (de) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti-modifiziertes peptid
EP1250933A1 (de) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Impfstoffe mit hochdosiertem Typ I IFN als Adjuvans
JPWO2003020306A1 (ja) * 2001-08-29 2004-12-16 伊東　恭悟 脱感作剤
WO2004037284A1 (en) 2002-10-22 2004-05-06 Sanofi Pasteur Limited Anti-cancer vaccines and high-dose cytokines as adjuvants
RU2546540C2 (ru) * 2011-07-06 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) Способ профилактики гриппа путем сочетанного применения интерферона гамма и инактивированной противогриппозной вакцины

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818445D0 (en) * 1998-08-24 1998-10-21 Imp College Innovations Ltd Medicaments

Also Published As

Publication number Publication date
ATE320266T1 (de) 2006-04-15
EP1074267B1 (de) 2006-03-15
DE60026666T2 (de) 2006-11-09
CA2313392A1 (en) 2001-01-22
EP1681064A1 (de) 2006-07-19
EP1074267A1 (de) 2001-02-07

Similar Documents

Publication Publication Date Title
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
DE69534778D1 (en) Cathepsin-02-protease
CZ63995A3 (en) Virus vectors and their use in gene therapy
NL192275B (nl) Eiwit van het AIDS-virus.
ATE241014T2 (de) Hiv-2 varianten
DK0523395T3 (da) Seroreaktive områder på proteinerne E1 og E2 i HPV 16
ATE199377T1 (de) Protein mit cytokinaktivität, rekombinant-dns, expressionsvektor und wirtszellen zu seiner herstellung
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
NO910103L (no) Non-a, non-b genomisk hepatittvirus cdna samt tilsvarendepolypeptid-antigen.
WO2001025438A3 (en) Ifn-alpha homologues
DK1147212T3 (da) T-hjælpecelle-epitoper
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
TR199901190T2 (xx) Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler.
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
FI970097A (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
ATE385805T1 (de) Neue peptide
DE69331977D1 (de) Löslicher LDL-Rezeptor, seine Herstellung und Verwendung
NO950420D0 (no) Interferon endelse derav
NO894573D0 (no) Rekombinante interleukin-2 hybridproteiner.
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69328488T2 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
EP1019500A4 (de) Neue ifn rezeptor 1 bindende proteine, dafür kodierende dna und verfahren zur regulierung der zellulären antwort auf interferone
FR2747681B1 (fr) Complexe proteique dodecaedrique adenoviral, composition le contenant et ses applications
IT1270941B (it) Peptidi di hcv e loro usi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee